Insmed (INSM) EBT Margin (2010 - 2026)
Insmed (INSM) recorded quarterly EBT Margin of 52.98% in Q1 2026, up 57.24% quarter-over-quarter from 123.91% in Q4 2025, and up 22246.0% on a YoY basis from N/an in Q1 2025.
Insmed (INSM) EBT Margin (2010 - 2026) Analysis & Trends
Insmed's EBT Margin history runs 12 years deep, the most recent figure standing at 52.98% for Q1 2026.
- In Q1 2026, EBT Margin rose 22246.0% year-over-year to 52.98%; the TTM figure through Mar 2026 stood at 143.76% (up 12111.0% YoY), while the FY2025 annual figure was 209.71%, up 4051.0% from the prior year.
- EBT Margin was 52.98% for Q1 2026 at Insmed, up from 123.91% in the prior quarter.
- In the past five years, EBT Margin ranged from a high of 52.98% in Q1 2026 to a low of 331.83% in Q2 2024.
- Historically, EBT Margin has averaged 222.13% across 5 years, with a median of 224.32% in 2024.
- The sharpest annual moves came in 2023 and 2026: EBT Margin sank 17043 bps in 2023, then jumped 22246 bps in 2026.
- A 5-year view of EBT Margin shows it stood at 269.81% in 2022, then grew by 18 bps to 221.12% in 2023, then fell by 1 bps to 224.32% in 2024, then jumped by 45 bps to 123.91% in 2025, then soared by 57 bps to 52.98% in 2026.
- The last three EBT Margin figures came in at 52.98% (Q1 2026), 123.91% (Q4 2025), and 259.02% (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | - |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | 6.40% |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | 41.95% |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | - |
| 10 | Insmed | 19.79 Bn | 18.57 Bn | 258.54 Mn | -52.98% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -52.98% |
| Dec 31, 2025 | -123.91% |
| Sep 30, 2025 | -259.02% |
| Jun 30, 2025 | -298.32% |
| Mar 31, 2025 | -275.44% |
| Dec 31, 2024 | -224.32% |
| Sep 30, 2024 | -234.96% |
| Jun 30, 2024 | -331.83% |
| Mar 31, 2024 | -207.29% |
| Dec 31, 2023 | -221.12% |
| Sep 30, 2023 | -200.31% |
| Jun 30, 2023 | -316.30% |
| Mar 31, 2023 | -244.24% |
| Dec 31, 2022 | -269.81% |
| Sep 30, 2022 | -193.08% |
| Jun 30, 2022 | -145.88% |
| Mar 31, 2022 | -177.45% |
| Dec 31, 2021 | -201.37% |
| Sep 30, 2021 | -246.58% |
| Jun 30, 2021 | -257.24% |